Across all DME patients dosed to date, 4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose ...

Heart disease is often associated with the heart and arteries, but its effects extend far beyond the cardiovascular system.

Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...

Striking a balance between innovation and responsibility is imperative. By prioritizing transparency, adhering to robust ...

French biochemist Jessie Inchauspé is sharing her tips to lower blood glucose levels, as part of her new Channel 4 show.

Over 537 million people globally suffer from diabetes, with 227 million in Asia Pacific. More than half may develop diabetic ...

The phase 3 trial showed biosimilar CT-P42 (Celltrion) is therapeutically equivalent to reference aflibercept in improving ...

The biotech industry is booming thanks to the rising demand for personalized medicine, investment in innovations, and ongoing ...

Fresenius, through its operating company Fresenius Kabi, is broadening its growing biopharma portfolio through a new licensing agreement with South Korea’s SamChunDang Pharm. Under the agreement, ...

Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding ...

The convergence of advanced technologies and advancements in drug delivery is reshaping diabetes care. Digital therapeutics ...